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Abstract
Background: Preterm and term newborns are at high risk of brain damage as well as subsequent cerebral palsy
and learning disabilities. Indeed, hypoxia-ischemia (HI), pathogen exposures, and associated intracerebral increase of
pro-inflammatory cytokines have all been linked to perinatal brain damage. However, the developmental effects of
potential variations of pro- and anti-inflammatory cytokine ratios remain unknown.
Methods: Using rat models of perinatal brain damage induced by exposures to lipopolysaccharide (LPS) and/or HI
at distinct levels of maturity, we compared cytokine expression at stages of cerebral development equivalent to
either preterm (postnatal day 1, P1) or term (P12) newborns.
Results: At P1, expression of anti-inflammatory cytokine within the brain was either not modulated (IL-6, IL-10) or
down-regulated (IL-1ra, TGF-b1) by HI, LPS or LPS+HI. In contrast, there was at P12 an up-regulation of all anti-
inflammatory cytokines studied in HI or LPS+HI condition, but not after LPS exposure. Interestingly, IL-1b was the
main pro-inflammatory cytokine up-regulated moderately at P1, and strongly at P12, with a weak co-expression of
TNF-a observed mainly at P12. These age-dependant inflammatory reactions were also accompanied, under HI and
LPS+HI conditions, at P12 only, by combined: (i) expression of chemokines CINC-1 and MCP-1, (ii) blood-brain
barrier (BBB) leakage, and (iii) intracerebral recruitment of systemic immune cells such as neutrophils. In contrast,
sole LPS induced IL-1b responses mainly within white matter at P1 and mainly within gray matter at P12, that
were only associated with early MCP-1 (but no CINC-1) induction at both ages, without any recruitment of
neutrophils and CD68+ cells.
Conclusion: HI and LPS+HI induce pro-inflammatory oriented immune responses in both preterm and term like
brains, with a maximal inflammatory response triggered by the combination of LPS+HI. The profile of these
neuroinflammatory responses presented striking variations according to age: no or down-regulated anti-
inflammatory responses associated with mainly IL-1b release in preterm-like brains (P1), in sharp contrast to term-
like brains (P12) presenting stronger anti-and pro-inflammatory responses, including both IL-1b and TNF-a releases,
and BBB leakage. These developmental-dependant variations of neuroinflammatory response could contribute to
the differential pattern of brain lesions observed across gestational ages in humans. This also highlights the
necessity to take into consideration the maturation stage, of both brain and immune systems, in order to develop
new anti-inflammatory neuroprotective strategies.
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Human newborns, especially preterm, are at high risk of
brain damage [1-4]. Decreased oxygen and other blood
nutrient supply to the brain, remote pathogen exposure,
or both combined, and the associated neuroinflamma-
tory responses are the most important perinatal risk fac-
tors associated with brain injury and subsequent
cerebral palsy and/or learning and behavioral impair-
ments [1-3]. The incidence of these forms of neonatal
brain damage is inversely proportional to gestational age
and thus higher in preterm than in term newborn [4].
Type and distribution of brain lesions differ markedly
between preterm and term newborns [4,5]. This is
attributed to different levels of brain maturity and vul-
nerability to aggression due to regional and age-specific
metabolic needs [1,2,4,5]. Post-natal bacterial infections
- that are more frequent in pre-term than term new-
borns -, and often combined with hypoxia-ischemia
(HI), are also associated with an increased risk to
develop brain lesions [6]. Our hypothesis is that devel-
opmental differences in neuroinflammatory responses
contribute to the age-specific patterns of brain injury.
Pro-inflammatory cytokine expression within the
brain, especially IL-1b and TNF-a, has been implicated
in perinatal brain damage induced by pathogen compo-
nents and/or HI both in experimental model [7-12] and
the human newborn brain [13-23]. On the other hand,
relatively little is known about anti-inflammatory and
neurotrophic cytokine responses in such perinatal brain
damage. Anti-inflammatory cytokines, such as IL-1
receptor antagonist (IL-1ra), IL-6, IL-10, and TGF-b1,
are already known either to be constitutively expressed
to support brain development, or to be induced in
pathological conditions to counterbalance the pro-
inflammatory response and to promote neuronal survi-
val [24-34]. Although IL-6 is often classified as a pro-
inflammatory mediator in peripheral pathologies, it has
not been directly implicated in perinatal brain damage
and its blockage was even showed to be deleterious in
some pathological circumstances [35,36]. During brain
development, IL-6 has established neurotrophic proper-
ties [35].
To uncover potential differences between term and
preterm neuroinflammatory responses to neonatal
insults, we used rat models of brain damage induced at
different stages of brain development. Postnatal day 1
(P1), corresponds, in term of brain development, to the
very preterm human brain (26-32 weeks of gestation),
whereas P12, corresponds to the term human neonate
brain [37]. We compared the intracerebral profiles of
pro- and anti-inflammatory cytokines responses, result-
ing chemokines responses, and related immune cell
recruitments at both developmental stages.
Methods
Animals
Lewis dams were purchased from Charles River Labora-
tories (Saint-Constant, Quebec, Canada) at embryonic
day 16 (E16) and gave birth naturally. At P1 or P12, rat
pups were injected intraperitoneally (ip) either with lipo-
polysaccharide (LPS; 200 μg/kg, Escherichia coli, 0127:
B8; Sigma, ON, Canada) diluted in 50 μl of saline, or
saline only. HI was induced 4 h after the LPS injection
by permanent ligation of the right common carotid
artery followed by exposure to 8% O2/N2 for 210 min at
P1 or 90 min at P12 in a chamber at 36°C as described
previously [38]. The duration of hypoxia was decreased
at P12 because of higher mortality rates of pups during
h y p o x i at h a na tP 1 .T h eP 1a n dP 1 2p u p sw e r er a n d o -
mized into five groups: (1) control, (2) sham, (3) HI, (4)
LPS, (5) LPS+HI. Pups were sacrificed by decapitation at
4, 24, 48 h and 8 days post-HI and brain were either
frozen and kept at -80°C for protein extraction or fixed
in paraformaldehyde and embedded in paraffin for
immunohistochemistry (IHC) (see below for details).
Since there was no difference between control and sham
animals, we presented only control group in our figures.
This protocol was duly approved by the appropriate
institutional Animal Research Ethics Board and con-
ducted in accordance with all applicable laws and
regulations.
Brain cytokines quantification
Both cerebral hemispheres were studied in combination
at P1 due to the presence of bilateral and symmetrical
brain damage, and of similar level of cytokine expression
(by IHC) between ipsi- and contralateral hemispheres in
animal exposed to LPS+/-HI at P1 as already shown in
HI condition [38], and in the present work in other con-
ditions (see Result Section). At P12, cerebral hemi-
spheres were studied separately since brain damage was
mostly unilateral. Proteins were extracted and concen-
trations determined as previously described [39]. Cyto-
kines (IL-1b,T N F - a, IL-10, IL-1ra, IL-6, TGF-b1) and
chemokines (MCP-1 and CINC-1) were quantified using
ELISA kits according to manufacturer’s instruction
(R&D System, MN, US; except for MCP-1: BD Bios-
ciences, NJ, US). ELISA for IL-1ra detection was per-
formed as described previously [7]. All samples were
analyzed in duplicate. Western blotting was used to
detect specific variation in the mature form of IL-1b as
previously described [39].
Immunohistochemistry
Total brains were embedded in paraffin and 5 μm-thick
sections were mounted on silanized slides. Brain sec-
tions were prepared as previously described [39].
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following primary antibodies directed against the follow-
ing proteins: IL-1b (1:50; #AAR15G, Serotec, NC, US),
TNF-a (1:50; #AB1837P Chemicon, ON, Canada), IL-10
(1:10; #MAB519, R&D System, MN, US), IL-1ra (1:25;
#sc-25444, Santa Cruz Biotechnology, CA, US), IL-6
(1:100; #MAB5061, R&D System, MN, US), TGF-b1
(1:100; #sc-146, Santa Cruz Biotechnology, CA, US),
MCP-1 (1:50; #AB1834P, Chemicon, ON, Canada),
CINC-1 (1:50; #CLLS-B2513, LifeSpan Biosciences, WA,
US), CD68 (1:250; #MAB1435, Chemicon, ON, Canada),
and with adsorbed antiserum directed against rat neu-
trophils (1:100; #CLAD51140, Cedarlane, ON, Canada).
For albumin detection, sections were incubated 2 h at
room temperature with IgG albumin fraction (1:100;
#55727, MP Biomedicals, OH, US) after blocking over-
night with 10% milk. The appropriate HRP-conjugated
secondary antibodies (anti-mouse, Cell Signaling Tech-
nology, MA, US; anti-rabbit, Serotec, NC, US; anti-
swine, Cedarlane, ON, Canada) were used for each
primary antibody and incubated for 1 h at room tem-
perature. Labeling was revealed using diaminobenzidene
(DAB) (Roche, Qc, Canada). Slides were counterstained
with hematoxylin. Cytokine and chemokine staining
intensities were measured in brain cortex and striatum,
both combined and referred to as gray matter, and in
adjacent subcortical/periventricular white matter (corpus
callosum and external capsule) using Image J program
(NIH) as described previously [23]. Quantitative com-
parisons were performed between staining intensities
from LPS +/- HI conditions compared to control. In our
IHC graphs, fold increases were determined against the
mean of the control group for each animal in each
experimental condition; data presented are thus the
mean+/-SEM fold variation from 3 to 4 animals in each
given experimental conditions. Neutrophils and CD68+
cells were counted in coronal sections at bregma level
-0.36 mm in the brain hemisphere ipsilateral to ische-
mia, as previously described [40].
Statistical analyses
Data are presented as mean ± standard error of the
mean (SEM). Comparisons between groups were per-
formed using one-way analysis of variance (ANOVA)
with the Student-Newman-Keuls post test and the
unpaired t-test with Welch correction. The significance
level was set at p < 0.05.
Results
A. Comparison of brain anti-inflammatory responses at P1
and P12 after LPS and/or HI exposure
We first assessed the impact of exposures to LPS and/or
HI on the expression of anti-inflammatory cytokines in
P1 and P12 pup brains. We quantified IL-10, IL-1ra,
IL-6 and TGF-b1 expressions in cerebral hemispheres
by ELISA. In P1 brain, LPS and/or HI did not induce
the expression of any of the anti-inflammatory cytokines
studied (IL-10, IL-1ra, IL-6 and TGF-b1) at 4 h, 24 h, or
48 h post-HI (the latter shown in Figure 1A-D). Brain
from P1 rat pups exposed to combined LPS+HI pre-
sented a decreased expression of TGF-b1( F i g u r e1 D )
compared to control level. In contrast, brain from P12
pups exposed to HI and LPS+HI, had up-regulated
levels of all anti-inflammatory cytokines in the hemi-
sphere ipsilateral to ischemia, as compared to control
condition (Figure 1A-D); HI and LPS+HI contralateral
hemisphere presenting similar levels of expression of
anti-inflammatory cytokine as control (data not shown).
The induction of IL-6 and TGF-b1 at P12 was detected
as early as 4 h post-HI and maintained until 48 h
(Figure 1C, D), expressions peaking at 48 h. On the
other hand, IL-1ra and IL-10 expressions at P12
were delayed, with a transient IL-1ra increase at 24 h
(Figure 1B), and up-regulation of IL-10 at 48 h post-HI
(Figure 1A). Administration of LPS prior to HI did not
lead, at P12, to any further increase of any anti-
inflammatory cytokines (IL-10, IL-1ra, IL-6, TGF-b1)
compared to HI alone.
The weaker induction of anti-inflammatory cytokines
at P1 compared to P12, i.e. at a developmental stage
corresponding to preterm versus term human brains,
likely reflects the immaturity of the intracerebral
immune response of the premature brain. This is further
supported by the basal intracerebral expression of anti-
inflammatory cytokines, which was also developmentally
regulated. Indeed, constitutive levels of expression were
higher at P12 than at P1 for all anti-inflammatory cyto-
kines studied (Figure 1E).
We then studied, by in situ IHC, the localization of
cytokine expression in different brain region, with a
special focus on those affected in human perinatal
brain damage, i.e. superficial (cortex) and deep (stria-
tum) gray matter, and adjacent white matter, at 48 h
(Figure 2A-D). At P1, no difference was detected in
both gray and white matter, in IL-6 (Figure 2A) and
IL-10 (Figure 2C) staining intensity under LPS and/or
HI conditions compared to control. At P12, HI and
LPS+HI increased IL-10 expression in both hemi-
spheric gray and white matters ipsilateral to ischemia
(Figure 2C, D). IL-6 expression (Figure 2A, B) at P12
followed a pattern similar to IL-10 but was increased
in both ipsi- and contralateral white matter under HI
and LPS+HI conditions as compared to control (data
not shown). TGF-b1 expression at P1 was down-regu-
lated in the gray matter of rat exposed to LPS+HI
(Figure 3A, B). In contrast, at P12, TGF-b1u p - r e g u l a -
tion was detected in both gray and white matters ipsilat-
eral to ischemia (Figure 3A, C) as well as in white
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expression was decreased in P1 pups 48 h after exposure
to HI, LPS or both combined (Figure 3D, E). Conversely,
an IL-1ra increase was detected in P12 rats at 48 h post-
HI and LPS+HI, but only in the gray matter of the hemi-
sphere ipsilateral to ischemia (Figure 3D, F).
B. Comparison between P1 and P12 intracerebral pro-
inflammatory responses to LPS and/or HI
The balance between pro and anti-inflammatory media-
tors and their interactions is known to determine the
magnitude of the inflammatory reaction. Thus, in addi-
tion to anti-inflammatory responses, we also used
Figure 1 Comparison between P1 and P12 ELISA titrations of brain anti-inflammatory cytokines. Developmentally regulated induction of
anti-inflammatory cytokines was shown after exposure to HI +/- LPS. An increased expression was detected after LPS and/or HI exposures at
P12, but not at P1, for IL-10 (A), IL-1ra (B), IL-6 (C) and TGF-b1( D). At P1, since the induction pattern was the same at 4, 24 or 48 h post-HI, only
48 h was shown. Control levels (E) of intracerebral cytokine titers were compared between P1 and P12. Protein detection was performed on 3 to
6 brains assayed in duplicate at each time point under each experimental condition. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with
Newman-Keuls post test (A-D) and t test with Welch correction (E).
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expression of pro-inflammatory cytokines, namely IL-1b
and TNF-a, following LPS and/or HI exposures. At P1,
we detected no TNF-a or modulation of total IL-1b
levels by ELISA in the brain (Figure 4A, B). However,
using western blotting to further distinguish between
pro and active forms of IL-1b, we detected a slight
increase of the active form of IL-1b (17 kDa) in brains
exposed to LPS+HI (Figure 4C, D). In contrast, both IL-
1b and TNF-a were up-regulated (IL-1b at a much
higher level than TNF-a) in P12 brains exposed to HI
and LPS+HI at 4, 24 and 48 h post-HI (Figure 4 A, B).
Using IHC, we then studied the distribution of pro-
inflammatory cytokines. Some rare foci of slight TNF-a
expression were detected by IHC at P1, only after com-
bined exposures to LPS+HI, in both gray and white
matter at 48 h (Figure 4E). At P12, TNF-a expression
was slightly increased after exposure to HI or combined
Figure 2 Comparison between P1 and P12 immunostaining intensities of IL-6 and IL-10 in brain.I L - 6a n dI L - 1 0e x p r e s s i o n sw e r e
increased only at P12 in brains of rat pups exposed to HI+/- LPS. Data are presented (A, C) as fold increase of IL-6 and IL-10 expressions
compared to control (set at 1). (B) Increased IL-6 staining (arrowheads) in P12 spongiotic frontal cortex (pyknotic neurons with abnormal
reduced contrast between nucleus and cytoplasm), and spongiotic underlying external capsule following LPS+HI exposure compared to control.
(D) Increased IL-10 staining (arrowheads) in P12 lesioned frontal cortex and underlying external capsule exposed to LPS+HI compared to control.
IHC was performed at 48 h post-HI, in 3 to 4 brains under each experimental condition. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA
with Newman-Keuls post test. Scale bars = 15 μm( B, D)
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matter (Figure 4E). IL-1b expression was also induced at
P1, in both gray and white matter of animals exposed to
HI and LPS+HI, and also in animals exposed to LPS
alone, but mainly in white matter (Figure 4F). At P12,
increased IL-1b immunoreactivity was detected at 48 h
in ipsilateral gray and white matters after HI or LPS+HI
(Figure 4F) as well as in contralateral white matter,
albeit to a lesser extent under the same experimental
conditions (data not shown).
C. Neuropathological changes, BBB permeability and
systemic immune cell recruitment
A systemic contribution of infiltrating macrophages and
neutrophils to the neuroinflammatory response has been
associated with HI induced brain damage, especially in
adult models. We therefore studied the intracerebral
recruitment of circulating immune cells and the expression
of related chemokines. Using ELISA, we quantified the
intracerebral expression of CINC-1 and MCP-1, which are
known to mediate the recruitment of neutrophils and
macrophages respectively. CINC-1 expression was induced
in both P1 and P12 pups brains after exposure to LPS+HI
at 4 h, and, to a lesser extent only at P12 at 48 h post-HI
(Figure 5A). However, this CINC-1 induction was greater
in P12 than P1 brains (2 fold higher). Those results were
confirmed by IHC showing at P12 - but not at P1 - a sus-
tained induction of CINC-1, in the gray matter, at 48 h
post HI and LPS+HI (Figure 5B, C). Infiltrating neutrophils
were detected at 48 h (but not at 4 h) after the aggressions,
in P12 brains exposed to HI (mean number of cells
counted in one section from ipsilateral hemisphere: 35 ±
28) or LPS+HI (mean number of cells counted in one sec-
tion from ipsilateral hemisphere: 110 ± 45) (Figure 5D, E).
In contrast, no neutrophils were detected in P1 brain
exposed to LPS and/or HI. No neutrophil was detected in
Figure 3 Comparison between P1 and P12 immunostaining intensities of TGF-b1 and IL-1ra in brain. TGF-b1 and IL-1ra expressions were
decreased at P1 and conversely increased at P12 in brains of rat pups exposed to HI and/or LPS. Data are presented (A, D) as fold increase of
TGF-b1 and IL-1ra expressions compared to control (set at 1). Decreased TGF-b1( B) and IL-1ra (E) staining in P1 frontal cortex exposed to LPS
plus HI versus control. Increased TGF-b1( C) and IL-1ra (F) staining (arrowheads) in P12 lesioned frontal cortex (pyknotic neurons with abnormal
reduced contrast between nucleus and cytoplasm), and underlying external capsule exposed to LPS+/-HI versus control. IHC was performed at
48 h post-HI, in 3 to 4 brains under each experimental condition. *p < 0.05, ***p < 0.001, one-way ANOVA with Newman-Keuls post test. Scale
bars = 15 μm( B, C, E, F).
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the experimental conditions used. Neutrophils were dis-
tributed in the lesioned area (mainly in gray matter of the
hemisphere ipsilateral to ischemia). The highest neutrophil
density - observed in LPS+HI condition - was associated
with both the highest level of CINC-1 expression within
gray matter, and the most extended histological brain
damage (Figure 5D, 6B and Table 1).
MCP-1 expression was induced early at P1 (at 4 and
24 h) and only after exposure to LPS or LPS+HI but not
HI alone (Figure 7A). At P12, MCP-1 levels were signifi-
cantly up-regulated, 4 and 24 h after exposure to HI,
LPS, or both combined, and this induction was more
i m p o r t a n tt h a na tP 1( 4f o l dh i g h e ra tP 1 2 ,F i g u r e7 A ) .
MCP-1 expression further increased and peaked at 24 h
after HI, and at 48 h after LPS+HI exposures. The com-
bined LPS+HI aggression led to more sustained expres-
sion than did HI alone (Figure 7A). Using IHC, we
confirmed that although MCP-1 levels were induced by
LPS and LPS+HI at early time points at P1, no change
was detected in intracerebral MCP-1 expression at 48 h
and no CD68+ cell was detected (Figure 7B). In con-
trast, at P12, we detected a significant increase, but only
in gray matter, of MCP-1 expression (Figure 7B, C). The
distribution of MCP-1 staining at P12 correlated with
the lesioned area (described in the Table 1 and shown
in Figure 6B) and also with the area displaying CD68+
infiltrating cells (Figure 7D, E). Some CD68+ cells were
also detected in the white matter of the hemisphere
contralateral to ischemia (data not shown).
Another major regulator of immune cell recruitment
is the integrity of the BBB, which can be altered by pro-
inflammatory cytokines [41,42]. We found that exposure
to HI with or without LPS led to a breakdown of the
BBB at P12 only, as shown by albumin extravasation
into the brain parenchyma detected 48 h post-HI
(Figure 6A). This BBB breakdown was more pronounced
within LPS+HI exposed brains than those exposed to HI
Figure 4 P1 versus P12 ELISA titrations and immunostaining intensities of cerebral pro-inflammatory cytokines, IL-1b and TNF-a. TNF-
a was not detected by ELISA at P1 but an up-regulation - weaker than the one observed for IL-1b - was detected at P12 after HI and LPS+HI
exposures by ELISA (A) and IHC in both white and gray matters (E). No modulation of combined pro- and active forms of IL-1b was detected by
ELISA between the different experimental conditions at P1 (B), whereas the active form (17 kDa) of IL-1b as detected by western blot was
increased in LPS+HI condition (C, D). Some foci of increased IL-1 immunostaining were detected by IHC in brain exposed to HI or LPS+HI, at 48
h post-HI (F). At P12, IHC results confirmed an increased IL-1b expression localized especially in gray, and in a lesser extent in white matter, of
brains exposed to HI and LPS+HI (F) and a TNF-a increase was detected only in the LPS+HI brains (E) at P1. Protein detection was performed by
ELISA on 3 to 4 brains assayed in duplicate, at each time point under each experimental condition. IHC and western blot were performed at 48
h post-HI, in 3 to 4 brains in each experimental condition. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Newman-Keuls post test,
except for LPS versus control at P1 in gray matter using t test with Welch correction.
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Page 7 of 14Figure 5 P1 versus P12 intracerebral expressions of CINC-1 and levels of neutrophil infiltrations. CINC-1 was detected by ELISA at 4 and
24 h after HI in P1 brains exposed to LPS+/-HI (A). No CINC-1 was detected at 48 h after HI in P1 brains exposed or unexposed to LPS+/-HI
either by ELISA (A) or IHC (data not shown) at 48 h post-HI. In contrast, following HI or LPS+HI at P12, CINC-1 was up-regulated in brains at 4, 24
and 48 h post-HI as shown by ELISA (A) and IHC experiments (B, C); this increase of CINC-1 intracerebral expression (C, arrowheads) at P12 was
present in the neocortical gray matter (C), but not in the underlying white matter. Neutrophils (E, arrowheads) were detected only at P12 - not at
P1 -, at 48 h post LPS+HI, in the neocortex ipsilateral to ischemia, i.e. in the areas of neocortical damage as illustrated in a schema (D). Protein
detection was performed by ELISA on 3 to 4 brains assayed in duplicate at each time point under each experimental condition. IHC was performed
at 48 h post-HI, in 3 to 4 brains under each experimental condition. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Newman-Keuls post
test, except for LPS+HI versus control at P12 (48 h) by ELISA using t test with Welch correction (A).Scale bars = 15 μm( C, E).
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areas of distribution of infiltrating immune cells (Figure
6C, see also 5D and 7D for each cell type distribution
separately). The areas of BBB disruption also spatially
matched with the infarcted area as seen at 8 days post-
HI (Figure 6A-C), and with the location of cytokines/
chemokines expression. No staining and no change in
albumin extravasation was detected in either gray or
white matter - in any of the experimental conditions
used - at earlier time points (i.e. 4 h at P12) or at P1.
Figure 6 BBB leakage and brain damage. Distribution of increased albumin staining within right hemispheric gray and white matters exposed
to HI, LPS or LPS+HI in P12 brains compared to control (A) correlated with injured areas (B, C). Brain injuries induced by HI and LPS+HI at P12
corresponded to infarcted areas (*) located in right carotidian territory; extent severity of infarct were maximum under LPS+HI compared to HI
(B). Schematic presentation of distribution of BBB leakage at P12, including albumin extravasations, PMN and CD68+ cells infiltrations in HI and
LPS+HI brains showing a topographic association between all these components of the neuroinflammatory response and brain damage (C).
Brain damage at P1 was detected in both white and gray matter (cortex and basal ganglia) (D). In contrast to P12 lesion, P1 brains submitted to
HI and LPS+HI presented laminar (D2, black arrowheads) or columnar (D3, black arrowheads) areas of neuronal necrosis (D2, D3, empty
arrowheads), linear microhemorrhage (D3, arrows) and foci of white matter damage (D1, black arrowheads) combining spongiotic cavities (D1,
empty arrowheads) and disorganization of cellular architecture (D1).
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and P12 are presented in the Table 1 and shown in
Figure 6B, D. No mast cell infiltration was detected in
P1 or P12 brains in any of the experimental conditions
used.
Discussion
Using animal models of brain insults occurring at neuro-
developmental stages equivalent to the preterm (P1) and
term (P12) human brain [37], we showed that exposures
to a bacterial endotoxin (LPS) and/or HI led to distinct
patterns of neuroinflammatory responses depending on
the stage of brain maturation, and on the type of insult.
At P1, the neuroinflammatory reaction triggered by HI,
LPS or LPS+HI was limited to IL-1b and MCP-1 - with
no TNF-a - over-expression, and without any concomi-
tant induction of classic counteracting anti-inflammatory
cytokines (see Table 1). IL-1b expression at P1 was more
prominent within the cerebral white matter than in the
gray matter, thus correlating with predominant white
matter damage occurrence previously described under
our P1 experimental conditions in rodents [40], and as
also typically seen in premature human newborns [4,43].
At P1, anti-inflammatory cytokines’ responses were
absent (IL-6, IL-10), or even down-regulated (IL-1ra,
TGF-b1) under HI, LPS or LPS+HI conditions. Lack of
anti-inflammatory response at P1 might deprive the chal-
lenged brain of neurotrophic factors - such as TGF-b1,
IL-10, IL-1ra and IL-6 - involved in neuronal survival
and brain tissue repair following brain injuries [7,44-53].
Therefore, this P1 pro-inflammatory orientation (mainly
intracerebral IL-1b and MPC-1 up-regulations) com-
bined with the vulnerability of the immature neural cells
might account for the brain damage induced (Table 1).
Well described IL-1b neurotoxic effects in conjunction
with other noxious mediators released by MCP-1
attracted macrophages, such as matrix metalloproteinases
(MMPs) and reactive oxygen species, might be involved
in the generation of such LPS+/-HI induced brain
damage at P1 [23,54].
At P12, in sharp contrast to P1, both pro- (IL-1b
peaking 8-fold higher than TNF-a at 4 h post LPS+HI)
and anti-inflammatory cytokines (namely IL-1ra, IL-6,
IL-10 and TGF-b1) were over-expressed within brains
exposed to HI or LPS+HI (Table 1). Despite the com-
bined induction of pro- and anti-inflammatory cytokines
at P12, the balance of pro/anti effects remained strongly
oriented towards inflammation, at a neurodevelopmental
stage equivalent to the term human brain. HI-, LPS- or
LPS+HI-induced chemokine responses (MCP-1 and/or
Table 1 Respective neuroinflammatory and neuropathological effects observed under each experimental condition in
preterm-like versus term-like brains
Insult P1 preterm-like forebrain P12 term-like forebrain
Pattern of neuroinflammatory
response
Neuropathological correlate Pattern of neuroinflammatory
response
Neuropathological correlate
LPS IL-1b (weak) increase with parallel
IL-1ra decrease in gray matter;
lack of modulation of other pro-
(TNF-a) or anti-inflammatory
cytokines. MCP-1 induction (gray
& white matter) likely via IL-1b/IL-
1ra unbalance.
No visible change by
hematoxylin staining.
Transient (4 h) and diffuse IL-1b
(high) increase with
dyscoordinated TNF-a decrease
(48 h) predominant in white
matter. No modulation of anti-
inflammatory cytokines. Transient
(4 h) MCP-1 increase, mainly in
gray matter, likely via IL-1b.
No visible change seen by
hematoxylin staining.
HI IL-1b (weak) increase (gray &
white matters) with parallel IL-1ra
decrease (gray matter). No
modulation of other pro- (TNF-a)
or anti-inflammatory cytokines. No
modulation of MCP-1 and CINC-1;
no PMN or CD68+ cell infiltration.
Slight degree of laminar or
columnar neuronal necrosis in
neocortex and basal ganglia; foci
of white matter damage. Possible
direct and indirect neurotoxicity
of IL-1b.
Sustained (4-48 h) IL-1b (high) and
TNF-a (weak) responses in gray &
white matter with late (24-48 h)
increase of anti-inflammatory
cytokines in both gray & white
matter. MCP-1 (4-24 h; high) and
CINC-1 (48 h; moderate)
inductions (possibly via IL-1b),
only in gray matter & subsequent
PMN and CD68+ cell infiltration
(moderate).
Infarcted areas in neocortex and
underlying white matter.
Possible neurotoxic effects of
PMN and/or IL-1b.
LPS
+HI
IL-1b (moderate) and TNF-a
(weak) increase (predominant in
white matter) with parallel
decrease of TGF-b1, IL-1ra (gray
matter) and IL-6 (diffuse). No IL-10
response. Brief CINC-1 and MCP-1
inductions (high) in gray matter,
likely via IL-1b, without any PMN
or CD68+ cell infiltration.
Compared to HI, more severe
and abundant laminar or
columnar areas of neuronal
necrosis in neocortex and basal
ganglia. Foci of white matter
damage. Possible direct and
indirect neurotoxicity of IL-1b.
Sustained (4-48 h) IL-1b (very high)
and TNF-a (moderate) responses
with late (24-48 h) increase of all
anti-inflammatory cytokines in
both gray & white matter. MCP-1
and CINC-1 increase (very high
and sustained (4-48 h)), possibly
IL-1-induced, within gray matter &
subsequent PMN and CD68+ cell
infiltrations (high).
Compared to HI, more extended
infarcted areas in neocortex and
adjacent white matter areas.
Possible neurotoxic effects of
PMN and/or IL-1b.
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Page 10 of 14Figure 7 P1 versus P12 intracerebral expressions of MCP-1 and levels of CD68+ cells. MCP-1 was detected at 4 and 24 h post-HI in pups
exposed to LPS +/-HI. No MCP-1 was detected 48 h after HI at P1 in brains exposed or unexposed to LPS+/-HI either by ELISA (A) or IHC (B)a t
48 h post-HI. In contrast, following HI or LPS+HI at P12, MCP-1 was up-regulated in brains at 4, 24 and 48 h post-HI as shown by ELISA (A). IHC
experiments (B, C) showed that this increased intracerebral MCP-1 expression (C, arrowheads) at P12 was only detected in the neocortex (C).
CD68+ cells (E, arrowheads) were detected at P12 - not at P1 - at 48 h post LPS+HI in the neocortex and white matter ipsilateral to ischemia, i.e.
in the areas of neocortical damage as illustrated in the schema (D). Protein detection was performed by ELISA on 3 to 4 brains assayed in
duplicate at each time point under each experimental condition. IHC was performed at 48 h post-HI, in 3 to 4 brains under each experimental
condition. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Newman-Keuls post test. Scale bars = 15 μm( C, E)
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Page 11 of 14CINC-1), known to derive in part from the activation of
the IL-1b pathway [55,56], were much more prominent
at P12 than at P1, particularly under LPS+HI conditions
compared to HI alone (Table 1). Combined, and likely
interacting, IL-1b,T N F - a and chemokine inductions
were also associated at P12 (but not at P1) with BBB
leakage and massive neutrophil infiltration within HI
and LPS+HI damaged brain areas. Known TNF-a myeli-
notoxicity and IL-1b neurotoxicity, joined to other neu-
rotoxic mediators released by neutrophils, such as
MMPs and reactive oxygen species, might well play a
central role in the induction of such brain damage
( T a b l e1 ) ,a sa l s os u g g e s t e db yn e o n a t a lh u m a nb r a i n
studies [7,18].
After identical endotoxin and/or HI exposures, prema-
ture human newborn commonly present patchy areas of
w h i t em a t t e rd a m a g ew h e r e as term newborns display
major cortico-subcortical infarcts associated with BBB
disruption and leukocyte infiltration [4]. The distinct
neuroinflammatory responses to similar aggressions
were documented in both preterm- (P1) and term-like
(P12) brains, and their mechanistic features might con-
tribute to the strikingly different age-dependent neuro-
pathological differences of perinatal brain damage
observed in rodents [38,40,57] as well as between pre-
term and term human newborns [4].
Systemic adaptive and innate immune responses of the
human neonates are known to differ from the adult’s
one in several ways, such as a bias towards Th2
response, and peripheral blood monocyte stimulation
from pathogens leading to higher IL-6, and IL-10
responses, but lower TNF-a expression than in the
adults [58,59]. Certain developmental comparisons have
already been performed between neonatal and adult
neuroinflammatory responses and across neonatal per-
iod [60,61]. For instance, a “window of susceptibility” to
intracerebral IL-1b exposure was detected in juvenile
(2-6 week-old) as opposed to neonatal (P1) or adult
(P90) rats, with juvenile rats displaying a peculiar age-
dependent hyper-response in term of neutrophil infiltra-
tion and neural cell damage [62-64]. Our experimental
data further delineate that over a short time frame, the
P1 brain reacts differently than the P12 brain following
exposure to systemic endotoxin and/or HI aggressions
(Table 1). Importantly, the recent demonstration of
much lower expression of TLR-4, within P1 rat brain
compared to slightly more mature rat brains, might pro-
vide a mechanistic explanation to our results [65]. The
neuroinflammatory response, even when induced at
both developmental stages, was weaker in P1 than in
P 1 2b r a i n si ni t sn e u r o t o x i c ,a sw e l la sn e u r o p r o t e c t i v e
components. In agreement with these experimental
results, both IL-1ra, IL-1b, and subsequent MMP-9
expressions were shown in situ, to be more weakly
expressed in preterm than in term damaged white mat-
ter from human brains [7]. In addition, studies testing
the transmigration across barriers of peripheral immune
cells showed only modest capacities for circulating leu-
cocytes, such as neutrophils, to migrate into the brain of
preterm human newborns as compared to term new-
borns [59]. This is known to be linked to immature
adhesion molecule expression by blood or BBB cells. In
addition, the reduced P1 (preterm-like) expressions of
MCP-1 and CINC-1 we showed at the most immature
stage of postnatal brain development might also contri-
bute to the weak preterm recruitment of systemic cells
(neutrophils and CD68+ cells) within the brain in our
model, as also observed by others [57,62]. In agreement
with the age-dependant level of CINC-1 production we
showed, neutrophils have been already shown to be
implicated - but only after P7 - in rat ischemic brain
damage, with a peak of deleterious effects at P12-P30
[37,62,64]. The fact that we did not detect any immune
cell recruitment at P1 as compared to P12 (and P7 as
described by others [64,66-68]), shows that the stage of
brain and immune system development is crucial in the
modulation of neuroinflammatory responses. Recent
data disclosed that the neonatal BBB is more mature
than previously thought, and that after an inflammatory
challenge at P1, the BBB was less permeable than later
on [62,69]. This is in keeping with our observations
showing that albumin extravasation and leucocytes infil-
trations across the BBB were abundant in rat brains
e x p o s e dt oH I ,o rL P S + H I ,a tP 1 2 ,b u ta b s e n tf o l l o w i n g
t h es a m ei n s u l t sa tP 1 .T h i sm i g h ta l s ob ed u et ot h e
weaker P1, than P12, neuroinflammatory response
avoiding BBB leakage.
Conclusion
In sum, following HI, LPS and combined LPS+HI, the
predominant pro-inflammatory IL-1b response within
the brains of preterm- and term-like neonates - what-
ever the level of anti-inflammatory cytokine response -
may have damaging effects at both stages of develop-
ment. However, the magnitude of the neuroinflamma-
tory response seems to be proportional to the intensity
of the IL-1b response as well as to the age-dependent
consequences on BBB permeability, chemokines
responses, and neutrophil infiltration.
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